As the novel coronavirus disease (COVID-19) spreads around the world and throughout the U.S., our professional community and policymakers, intended parents, donors, surrogates, third-party ART agencies, and the public in general are seeking advice regarding how those who are undergoing or planning infertility treatment should proceed in light of COVID-19-related travel bans and other public health advisories.